...
首页> 外文期刊>British Journal of Pharmaceutical Research >Effects of Crystal Derived from Stevia rebaudiana Leaves on Alloxan Induced Type-1 Diabetic Mice
【24h】

Effects of Crystal Derived from Stevia rebaudiana Leaves on Alloxan Induced Type-1 Diabetic Mice

机译:甜叶菊叶结晶对四氧嘧啶诱导的1型糖尿病小鼠的影响

获取原文

摘要

The study was undertaken to investigate the antidiabetic effects of crystals derived from Stevia rebaudiana leaves in normal rats and alloxan induced diabetic mice. Normal rats were used to evaluate whether the stevia crystal have any adverse effects on body weight and blood glucose of healthy rats. The rats were divided into two groups (n=5); healthy control rats and stevia treated healthy rats (1 g/kg/day orally). To evaluate the antidiabetic effects of stevia crystal, mice were divided into five equal (n=5) groups; healthy control, diabetic control, stevia crystal @ 250 and 500 mg/kg bwt, and Amaryl? @ 800 μg/kg daily to compare the efficacy. Alloxan monohydrate was injected in mice at a dose rate of 120 mg/kg intraperitoneally for diabetic induction. Result of the present study showed that stevia crystal at a high daily dose did not have any significant effect on body weight but it reduced blood glucose level non-significantly in healthy animal. The antidiabetic effects of stevia crystal was evaluated based on glucose lowering capacity, improvement of body weight loss, changes in lipid profile, and renal and pancreas protective capacity. Treatment with stevia crystal @500 mg/kg improved body weight loss and reduced blood glucose level significantly ( P <0.01) in diabetic animal. Stevia @500 mg/kg decreased cholesterol level non-significantly whereas it reduce the triglyceride level significantly ( P <0.01). In histopathology study, stevia crystal showed renal and pancreas protective effect with slightly restoration of structural damage in both organs. Based on present studies data it may conclude that crystalline compounds derived from Stevia rebaudiana leaves may have antidiabetic properties that need further characterization.
机译:进行了这项研究以研究甜叶菊叶晶体的结晶对正常大鼠和四氧嘧啶诱导的糖尿病小鼠的抗糖尿病作用。正常大鼠用于评估甜菊糖晶体是否对健康大鼠的体重和血糖有任何不利影响。将大鼠分成两组(n = 5);将它们分为两组。健康对照大鼠和甜菊糖治疗的健康大鼠(口服1 g / kg /天)。为了评估甜菊糖晶体的抗糖尿病作用,将小鼠分为五个相等的组(n = 5);健康对照,糖尿病对照,甜菊糖晶体@ 250和500 mg / kg bwt,以及Amaryl ? @ 800μg/ kg,以比较疗效。一氧化二氧嘧啶一水合物以120mg / kg的剂量率腹膜内注射到小鼠中以诱导糖尿病。本研究结果表明,高剂量的甜菊糖晶体对体重没有明显影响,但对健康动物的血糖水平无明显影响。根据降低葡萄糖的能力,改善体重减轻,脂质分布的变化以及肾脏和胰腺的保护能力来评估甜菊糖晶体的抗糖尿病作用。在糖尿病动物中,以500 mg / kg的甜菊糖晶体治疗可显着改善体重减轻并降低血糖水平(P <0.01)。甜叶菊@ 500 mg / kg显着降低胆固醇水平,而显着降低甘油三酸酯水平(P <0.01)。在组织病理学研究中,甜叶菊晶体显示出对肾脏和胰腺的保护作用,并在两个器官中略微恢复了结构损伤。根据目前的研究数据,可以得出结论,源自甜叶菊叶的结晶化合物可能具有抗糖尿病特性,需要进一步表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号